Houston as a Biomedical Innovation Hub Connecting Texas to Asia and Beyond

Join us for a discussion on the importance of maintaining and building connections between Houston’s biomedical community and Asia, as well as the need to build a critical mass to ensure Houston becomes a long-term global hub of biomedical innovation. The discussion will feature Ann Tanabe, CEO of BioHouston; Dr. Ferran Prat, Senior Vice President of Research Administration and Industry Ventures at MD Anderson Cancer Center; Tracey Davies, Chief Strategic Initiatives and Intellectual Property Officer; Eric Johnson, Executive Managing Director for Transwestern’s Life Science Advisory Services Group; and Convergence Venture’s partner John Nghiem.